Abstract
Osteoporosis is defined by low bone quality, strength and increased fracture risk. Primary and secondary osteoporosis are the two forms of osteoporosis classified on the basis of factors affecting the metabolism of bone. Primary osteoporosis develops as a result of aging or menopause-related bone demineralization. Type I/postmenopausal and type II/senile osteoporosis are two subtypes of primary osteoporosis. Secondary osteoporosis is due to pathological conditions and medications other than aging and menopause that lead to deprivation of bone mass and elevated fracture risk. Classification of osteoporosis based on BMD testing with DEXA devised by the World Health Organization utilizes T-score in BMD reporting of women in menopausal transition or postmenopause and men ≥ 50 years. Z-scores are preferred, while BMD reporting in premenopausal women, adults < 50 years of age, and children. BMD alone is not diagnostic of osteoporosis in men < 50 years. The Fracture Risk Assessment Tool Model (FRAX) is a software algorithm that incorporates significant predictors of fracture risk and BMD in individuals to predict the risk of fracture. FRAX predicts the “10-year probability of a major fracture (hip, clinical spine, humerus, or wrist fracture) and the 10-year probability of a hip fracture”.
Similar content being viewed by others
References
International Osteoporosis Foundation | IOF [Internet]. [cited 2023 Oct 27]. Available from https://www.osteoporosis.foundation/.
Gregson, C. L., Armstrong, D. J., Bowden, J., Cooper, C., Edwards, J., Gittoes, N. J. L., et al. (2022). UK clinical guideline for the prevention and treatment of osteoporosis. Archives of Osteoporosis, 17(1), 1–46. https://doi.org/10.1007/s11657-022-01061-5
Chandran, M., Brind’Amour, K., Fujiwara, S., Ha, Y. C., Tang, H., Hwang, J. S., et al. (2023). Prevalence of osteoporosis and incidence of related fractures in developed economies in the Asia Pacific region: A systematic review. Osteoporosis International, 34(6), 1037–1053. https://doi.org/10.1007/s00198-022-06657-8
Shen, Y., Huang, X., Wu, J., Lin, X., Zhou, X., Zhu, Z., et al. (2022). The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories 1990–2019. Frontiers in Endocrinology (Lausanne). https://doi.org/10.3389/fendo.2022.882
Kaushal, N., Vohora, D., Jalali, R. K., & Jha, S. (2018). Prevalence of osteoporosis and osteopenia in an apparently healthy Indian population—A cross-sectional retrospective study. Osteoporosis and Sarcopenia, 4(2), 53–60.
Bachrach, L. K., & Gordon, C. M. (2016). Bone densitometry in children and adolescents. Pediatrics. https://doi.org/10.1542/peds.2016-2398
Marcus, R., Feldman, D., Dempster, D. W., Luckey, M., & Cauley, J. A. (1995). Osteoporosis (4th ed.). Elsevier.
Lu, Y., Genant, H. K., Shepherd, J., Zhao, S., Mathur, A., Fuerst, T. P., et al. (2001). Classification of osteoporosis based on bone mineral densities. Journal of Bone and Mineral Research, 16(5), 901–910. https://doi.org/10.1359/jbmr.2001.16.5.901
Varacallo, M. A., & Fox, E. J. (2014). Osteoporosis and its complications. Medical Clinics of North America, 98(4), 817–831. https://doi.org/10.1016/j.mcna.2014.03.007
Kanis, J. A., & Kanis, J. A. (1994). Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. WHO Study Group. Osteoporosis International, 4(6), 368–381.
Adult Positions—ISCD [Internet]. [cited 2023 Oct 28]. Available from https://iscd.org/learn/official-positions/adult-positions/.
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., et al. (2014). Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International, 25(10), 2359–2381.
Hannan, M. T., Felson, D. T., Dawson-Hughes, B., Tucker, K. L., Cupples, L. A., Wilson, P. W. F., et al. (2000). Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. Journal of Bone and Mineral Research, 15(4), 710–720.
Gallagher, J. C., & Rapuri, P. B. (2003). Osteoporosis: Pathophysiology. In H. L. Henry & A. W. Norman (Eds.), Encyclopedia of HORMONES (pp. 89–98). Academic Press.
Cosman, F., de Beur, S. J., LeBoff, M. S., Lewiecki, E. M., Tanner, B., Randall, S., et al. (2014). Clinician’s guide to prevention and treatment of osteoporosis. Osteoporosis International., 25(10), 2359.
(US) O of the SG. Bone health and osteoporosis. US Health and Human Services [Internet]. 2004 [cited 2023 Nov 5];437. Available from https://www.ncbi.nlm.nih.gov/books/NBK45513/.
Sözen, T., Özışık, L., & Başaran, N. Ç. (2017). An overview and management of osteoporosis. European Journal of Rheumatology, 4(1), 46.
Lewiecki, E.M. Osteoporosis: Clinical evaluation. Endotext [Internet]. 2021 Jun 7 [cited 2023 Oct 26]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK279049/.
Lewiecki, E. M. (2022). Evaluating patients for secondary causes of osteoporosis. Current Osteoporosis Reports., 20(1), 1–12.
Shuhart, C. R., Yeap, S. S., Anderson, P. A., Jankowski, L. G., Lewiecki, E. M., Morse, L. R., et al. (2019). Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics. Journal of Clinical Densitometry, 22(4), 453–471.
Sheu, A., & Diamond, T. (2016). Bone mineral density: Testing for osteoporosis. Australian Prescriber, 39(2), 35–39.
Berger, A. (2002). How does it work?: Bone mineral density scans. British Medical Journal (BMJ), 325(7362), 484.
Arabi, A., Baddoura, R., Awada, H., Khoury, N., Haddad, S., Ayoub, G., et al. (2007). Discriminative ability of dual-energy X-ray absorptiometry site selection in identifying patients with osteoporotic fractures. Bone, 40(4), 1060–1065.
Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J. Y. (2018). Review of the guideline of the American College of Physicians on the treatment of osteoporosis. Osteoporosis International., 29(7), 1505–1510.
Saraff, V., & Högler, W. (2015). Osteoporosis in children: Diagnosis and management. European Journal of Endocrinology, 173(6), R185–R197.
Ciancia, S., van Rijn, R. R., Högler, W., Appelman-Dijkstra, N. M., Boot, A. M., Sas, T. C. J., et al. (2022). Osteoporosis in children and adolescents: When to suspect and how to diagnose it. European Journal of Pediatrics, 181(7), 2549.
Cimaz, R. (2014). Pediatric osteoporosis. Pediatric Rheumatology. https://doi.org/10.1186/1546-0096-12-S1-I27
Munns, C. (2015). Treatment of childhood osteoporosis—Current and future perspectives. International Journal of Pediatric Endocrinology. https://doi.org/10.1186/1687-9856-2015-S1-O11.
Golden, N. H., Abrams, S. A., Daniels, S. R., Corkins, M. R., De Ferranti, S. D., Magge, S. N., et al. (2014). Optimizing bone health in children and adolescents. Pediatrics, 134(4), e1229–e1243.
Pediatric Positions—ISCD [Internet]. [cited 2023 Oct 27]. Available from https://iscd.org/learn/official-positions/pediatric-positions/.
The International Society for Clinical Official Positions. [cited 2023 Oct 27]. Available from www.iscd.org.
Bacchetta, J., Wesseling-Perry, K., Gilsanz, V., Gales, B., Pereira, R. C., & Salusky, I. B. (2013). Idiopathic juvenile osteoporosis: A cross-sectional single-centre experience with bone histomorphometry and quantitative computed tomography. Pediatric Rheumatology. https://doi.org/10.1186/1546-0096-11-6
Franceschi, R., Vincenzi, M., Camilot, M., Antoniazzi, F., Freemont, A. J., Adams, J. E., et al. (2015). Idiopathic juvenile osteoporosis: Clinical experience from a Single centre and screening of LRP5 and LRP6 genes. Calcified Tissue International., 96(6), 575–579.
Lorenc, R. S. (2002). Idiopathic juvenile osteoporosis. Calcified Tissue International, 70(5), 395–397.
Seeman, E., & Delmas, P. D. (2006). Bone quality—The material and structural basis of bone strength and fragility. New England Journal of Medicine, 354(21), 2250–2261.
Kanis, J. A., Odén, A., Johansson, H., & McCloskey, E. V. (2013). Fracture risk assessment: The development and application of FRAX®. Osteoporosis (4th ed., pp. 1611–1637). Academic Press.
Kanis, J. A., McCloskey, E. V., Johansson, H., Strom, O., Borgstrom, F., Oden, A., et al. (2008). Case finding for the management of osteoporosis with FRAX—Assessment and intervention thresholds for the UK. Osteoporosis International, 19(10), 1395–1408.
Funding
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical Standard Statement
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed Consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Amarnath, S.S., Kumar, V. & Das, S.L. Classification of Osteoporosis. JOIO 57 (Suppl 1), 49–54 (2023). https://doi.org/10.1007/s43465-023-01058-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43465-023-01058-3